Terms: = Thyroid cancer AND MAPK1, MAPK2, 5594, ENSG00000100030, P28482, ERK2, p40, PRKM1, p38, p41, ERT1, p41mapk, PRKM2, P42MAPK, ERK AND Clinical Outcome
3 results:
1. ATF4 Targets RET for Degradation and Is a Candidate Tumor Suppressor Gene in Medullary thyroid cancer.
Bagheri-Yarmand R; Williams MD; Grubbs EG; Gagel RF
J Clin Endocrinol Metab; 2017 Mar; 102(3):933-941. PubMed ID: 27935748
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological Features of Low-Grade thyroid-like Nasopharyngeal Papillary Adenocarcinoma.
Li M; Wei J; Yao X; Wang C
Cancer Res Treat; 2017 Jan; 49(1):213-218. PubMed ID: 27384157
[TBL] [Abstract] [Full Text] [Related]
3. Does immunohistochemistry affect response to therapy and survival of inoperable non-small cell lung carcinoma patients? A survey of 145 stage III-IV consecutive cases.
Pelosi G; Haspinger ER; Bimbatti M; Leone G; Paolini B; Fabbri A; Tamborini E; Perrone F; Testi A; Garassino M; Maisonneuve P; de Braud F; Pilotti S; Pastorino U
Int J Surg Pathol; 2014 Apr; 22(2):136-48. PubMed ID: 24326823
[TBL] [Abstract] [Full Text] [Related]
